| Literature DB >> 34908962 |
Alessio Gori1,2,3, Eleonora Topino2, Ilaria Bagnoli2, Giuseppe Iraci-Sareri3,4, Giuseppe Craparo5.
Abstract
OBJECTIVE: Several studies have been conducted to investigate the relationship between addiction and crimes, but little is known about the treatment of individuals with substance use disorder (SUD) with criminal records. This study aimed to assess the treatment progress of a group of individuals with SUD who underwent treatment within a residential community, and to analyze their personality profiles to identify drop-out predictors.Entities:
Keywords: addiction; assessment; process-outcome research; psychological treatment; psychotherapy
Year: 2020 PMID: 34908962 PMCID: PMC8629052 DOI: 10.36131/clinicalnpsych20200102
Source DB: PubMed Journal: Clin Neuropsychiatry ISSN: 1724-4935
Sociodemographic Characteristic of the sample
| Sociodemographic Characteristics | |||
|---|---|---|---|
|
| M= 36.83, SD= 8.25 | ||
|
| |||
|
|
| ||
|
| 43 | 87.5 | |
|
| 6 | 12.5 | |
|
| |||
|
| 48 | 98 | |
|
| 1 | 2 | |
|
| |||
|
| 38 | 76.6 | |
|
| 3 | 6.4 | |
|
| 3 | 6.4 | |
|
| 2 | 4.3 | |
|
| 3 | 6.4 | |
|
| |||
|
| 4 | 8.5 | |
|
| 22 | 44.7 | |
|
| 22 | 44.7 | |
|
| 1 | 2.1 | |
Legal features of the sample
|
| ||
|---|---|---|
| Type of crime | ||
|
| % | |
|
| 1 | 2.0 |
|
| 3 | 6.1 |
|
| 1 | 2.0 |
|
| 5 | 10.2 |
|
| 2 | 4.1 |
|
| 3 | 6.1 |
|
| 32 | 65.3 |
|
| 2 | 4.1 |
|
| ||
|
| 10 | 21.3 |
|
| 6 | 12.8 |
|
| 21 | 42.6 |
|
| 4 | 8.5 |
|
| 8 | 14.9 |
|
| ||
|
| 12 | 24.5 |
|
| 1 | 2.0 |
|
| 3 | 6.1 |
|
| 2 | 4.1 |
|
| 7 | 14.3 |
|
| 6 | 12.2 |
|
| 7 | 14.3 |
|
| 11 | 22.4 |
ANOVA among the groups in relation to Diagnostic Categories and to the state of treatment (PTI scale) – part I
| PTI Scales | Diagnostic Categories |
|
| State of Treatment |
|
| ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mood Disorder | Personality Disorder | Psychotic Disorder | Conclusion | Drop-out | In-Treatment | |||||||||||
| N | M (SD) | N | M (SD) | N | M (SD) | N | M (SD) | N | M (SD) | N | M (SD) | |||||
|
| ||||||||||||||||
|
| 11 | 7.64 (1.29) | 24 | 6.75 (1.54) | 12 | 5.25 (1.42) | 8.06 | . | 12 | 6.25 (2.22) | 12 | 7.17 (1.40) | 25 | 6.92 (1.71) | .88 | .42 |
|
| 11 | 1.27 (1.19) | 24 | 1.54 (.98) | 12 | 1.67 (.78) | .48 | .621 | 12 | 1.83 (1.19) | 12 | 1.67 (.98) | 25 | 2.20 (1.19) | 1.01 | .37 |
|
| 11 | 3.63 (1.43) | 24 | 2.67 (1.13) | 12 | 2.42 (.90) | 3.68 | . | 12 | 2.83 (.72) | 12 | 3 (1.54) | 25 | 3.12 (1.42) | .19 | .83 |
|
| 11 | 4 (.89) | 24 | 3.25 (1.26) | 12 | 3 (1.28) | 2.24 | .119 | 12 | 3.42 (1.24) | 12 | 3.17 (1.19) | 25 | 3.24 (1.13) | .15 | .86 |
|
| 11 | 3.73 (1.35) | 24 | 3.96 (1.04) | 12 | 3.42 (1.38) | .814 | .450 | 12 | 4 (.85) | 12 | 3.17 (1.75) | 25 | 3.48 (1.48) | 1.05 | .36 |
|
| ||||||||||||||||
|
| 11 | 19.73 (.85) | 24 | 17.50 (3.93) | 12 | 20.67 (5.55) | 2.40 | .103 | 12 | 19.08 (4.50) | 12 | 16.17 (4.41) | 25 | 20.28 (5.13) | 2.96 | .062 |
|
| 11 | 13.27 (3.5) | 24 | 11.04 (2.14) | 12 | 13.83 (3.19) | 4.97 |
| 12 | 12.17 (3.07) | 12 | 10.58 (2.87) | 25 | 13.76 (2.67) | 5.33 |
|
|
| 11 | 17.18 (5.34) | 24 | 15.88 (3.09) | 12 | 20.58 (3.06) | 5.29 |
| 12 | 15.92 (4.50) | 12 | 15.08 (4.01) | 25 | 19.88 (3.73) | 7.49 |
|
|
| 11 | 17.18 (5.19) | 24 | 17.17 (3.34) | 12 | 19.33 (3.31) | 1.42 | .253 | 12 | 17.58 (3.15) | 12 | 14.58 (4.70) | 25 | 19.44 (5.51) | 4.09 |
|
|
| 11 | 19.82 (4.58) | 24 | 19.50 (5.26) | 12 | 23.17 (5.81) | 2.07 | .139 | 12 | 18 (6.09) | 12 | 17.67 (3.87) | 25 | 20.52 (4.63) | 1.88 | .163 |
|
| 11 | 16 (5.33) | 24 | 16.88 (5.64) | 12 | 18.17 (6.69) | .40 | .670 | 12 | 14.58 (5.58) | 12 | 16 (7.07) | 25 | 17.88 (6.20 | 1.19 | .313 |
|
| 11 | 9.64 (3.67) | 24 | 10.29 (3.92) | 12 | 11.58 (4.10) | .76 | .473 | 12 | 10.17 (4.06) | 12 | 10.42 (3.82) | 25 | 8.80 (3.34) | 1.04 | .361 |
|
| 11 | 14.18 (6.52) | 24 | 9.58 (4.28) | 12 | 12.08 (3.73) | 3.73 | .032 | 12 | 10.58 (4.96) | 12 | 10.67 (5.79) | 25 | 11.48 (5.28) | .16 | .854 |
|
| 11 | 9.73 (4.61) | 24 | 10.46 (4.15) | 12 | 9.83 (2.69) | .17 | .841 | 12 | 11.08 (4.14) | 12 | 9.83 (4.99) | 25 | 9.08 (3.09) | 1.08 | .347 |
|
| 11 | 11 (3.85) | 24 | 11 (4.60) | 12 | 14.25 (2.93) | 2.85 | . | 12 | 11.92 (4.78) | 12 | 12.25 (5.28) | 25 | 11.76 (3.94) | .05 | .953 |
|
| ||||||||||||||||
|
| 11 | 9.27 (5.64) | 24 | 10.25 (4.65) | 12 | 12.92 (5.20) | 1.71 | .193 | 12 | 11.25 (6.18) | 12 | 11 (6.12) | 25 | 10.40 (3.62) | .14 | .873 |
|
| 11 | 9.82 (5.79) | 24 | 10.42 (5.10) | 12 | 11.33 (2.42) | .30 | .742 | 12 | 11.17 (6.74) | 12 | 9.25 (3.98) | 25 | 10.32 (4.11) | .47 | .626 |
|
| 11 | 10.27 (3.55) | 24 | 9.58 (3.65) | 12 | 11.75 (3.96) | 1.37 | .265 | 12 | 9.92 (4.12) | 12 | 11.25 (4.77) | 25 | 10.68 (3.22) | .36 | .699 |
|
| 11 | 8.09 (3.96) | 24 | 9.17 (4.57) | 12 | 9.17 (4.57) | 1.76 | .184 | 12 | 9.08 (4.17) | 12 | 9 (5.10) | 25 | 9.36 (2.91) | .04 | .958 |
|
| 11 | 8.82 (5.49) | 24 | 10.67 (4.26) | 12 | 10.75 (3.55) | .76 | .472 | 12 | 11.75 (5.97) | 12 | 9.83 (4.47) | 25 | 9.72 (4.28) | .79 | .460 |
|
| 11 | 10.75 (3.55) | 24 | 13.67 (6.77) | 12 | 17.83 (6.12) | 2.15 | .129 | 12 | 13 (8.62) | 12 | 10.67 (4.08) | 25 | 12.60 (6.40) | .46 | .633 |
|
| 11 | 14.45 (10.08) | 24 | 13.08 (5.87) | 12 | 21.33 (6.07) | 5.57 | . | 12 | 15.17 (9.74) | 12 | 15.67 (6.53) | 25 | 16.88 (9.11) | .18 | .834 |
|
| 11 | 11.73 (1.43) | 24 | 12.88 (1.13) | 12 | 17.17 (.90) | 5.01 |
| 12 | 14.58 (4.74) | 12 | 14.42 (5.66) | 25 | 13 (4.59) | .58 | .566 |
|
| 11 | 10 (4.73) | 24 | 11.25 (6.39) | 12 | 13.08 (5.35) | .84 | .441 | 12 | 10.67 (4.40) | 12 | 11.83 (7.65) | 25 | 11.24 (5.27) | .12 | .884 |
|
| 11 | 6 (2.37) | 24 | 6.17 (2.91) | 12 | 10 (4.02) | 6.92 |
| 12 | 6.50 (2.97) | 12 | 6.83 (3.66) | 25 | 6.72 (3.49) | .03 | .970 |
*Significant differences among Diagnostic Categories;
**Significant differences among different states of treatment;
***Significant differences in both Diagnostic Categories and State of treatment
ANOVA among the groups in relation to Diagnostic Categories and to the state of treatment (PTI scale) – part II
| PTI Scales | Diagnostic Categories |
|
| State of Treatment |
|
| ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mood Disorder | Personality Disorder | Psychotic Disorder | Conclusion | Drop-out | In-Treatment | |||||||||||
| N | M (SD) | N | M (SD) | N | M (SD) | N | M (SD) | N | M (SD) | N | M (SD) | |||||
|
| ||||||||||||||||
|
| 11 | 19.09 (6.44) | 24 | 17.63 (4.76) | 12 | 18.33 (3.31) | .35 | .708 | 12 | 16.83 (4.02) | 12 | 17.25 (4.16) | 25 | 18.64 (5.27) | .72 | .493 |
|
| 11 | 15.82 (6.43) | 24 | 14.33 (3.29) | 12 | 12.67 (3.89) | 1.52 | .230 | 12 | 14.67 (6.57) | 12 | 15.17 (4.32) | 25 | 15.20 (4.08) | .05 | .949 |
|
| 11 | 12.36 (5.73) | 24 | 12.79 (4.09) | 12 | 14 (5.98) | .35 | .708 | 12 | 12.83 (3.97) | 12 | 12.17 (5.17) | 25 | 12.64 (5.14) | .06 | .941 |
|
| 11 | 5.09 (2.17) | 23 | 6.65 (2.76) | 12 | 7.75 (1.81) | 3.51 |
| 12 | 6.50 (2.65) | 12 | 6.33 (3.06) | 25 | 5.80 (2.12) | .39 | .682 |
|
| 11 | 9.45 (4.32) | 23 | 10.13 (2.88) | 12 | 12.75 (3.70) | 3.10 | . | 12 | 9.42 (3.90) | 12 | 8.50 (3.34) | 25 | 11.64 (4.00) | 3.18 | . |
|
| 11 | 4.73 (2.15) | 23 | 7.17 (2.62) | 12 | 8 (3.19) | 4.71 |
| 12 | 6.58 (2.47) | 12 | 5.75 (2.09) | 25 | 6.16 (2.48) | .37 | .696 |
|
| ||||||||||||||||
|
| 10 | 17.90 (4.01) | 23 | 16.17 (4.38) | 12 | 17.50 (4.76) | .68 | .512 | 10 | 14.60 (3.57) | 11 | 15.00 (4.34) | 25 | 17.60 (4.27) | 2.61 | .086 |
|
| 10 | 9 (1.78) | 23 | 13.96 (5.66) | 12 | 16.92 (4.78) | 6.62 |
| 10 | 13.90 (5.93) | 11 | 11.73 (5.06) | 25 | 13 (5.10) | .46 | .637 |
|
| 10 | 11.60 (5.32) | 23 | 10.78 (4.71) | 12 | 12.25 (6.09) | .32 | .725 | 10 | 10.21 (3.99) | 11 | 10.55 (3.62) | 25 | 11 (4.25) | .15 | .860 |
|
| 10 | 7 (1.56) | 23 | 8.70 (4.38) | 12 | 10.58 (4.58) | 2.20 | .123 | 10 | 7.30 (1.49) | 11 | 8.18 (4.00) | 25 | 9.04 (3.86) | .91 | .410 |
|
| 11 | 16.18 (1.54) | 24 | 16.08 (3.24) | 12 | 19.17 (4.47) | 3.80 |
| 10 | 15.83 (3.13) | 11 | 15.17 (3.16) | 25 | 17 (3.52) | 1.35 | .270 |
|
| 11 | 11 (4.38) | 24 | 11.88 (4.60) | 12 | 12.25 (2.53) | .28 | .757 | 10 | 10.50 (4.46) | 11 | 10.50 (3.09) | 25 | 11.84 (3.87) | .74 | .483 |
|
| 11 | 9.72 (2.94) | 24 | 11.29 (2.61) | 12 | 12.92 (2.50) | 4.12 |
| 10 | 11.17 (2.95) | 11 | 10.58 (2.84) | 25 | 11.28 (2.91) | .24 | .787 |
|
| 11 | 11.09 (4.59) | 24 | 11.83 (3.67) | 12 | 15.17 (4.57) | 3.46 |
| 10 | 10.83 (3.27) | 11 | 11.33 (4.03) | 25 | 13.04 (4.57) | 1.40 | .258 |
|
| 11 | 9.18 (3.37) | 24 | 11.96 (4.36) | 12 | 12.83 (5.08) | 2.25 | .117 | 12 | 11.42 (4.08) | 12 | 11 (4.11) | 25 | 11.40 (4.33) | .04 | .959 |
|
| 11 | 9.81 (2.27) | 24 | 11.71 (3.82) | 12 | 12.42 (4.25) | 1.58 | .217 | 12 | 11.17 (3.69) | 12 | 10.33 (2.93) | 25 | 10.76 (3.49) | .18 | .837 |
|
| 11 | 10.64 (3.93) | 24 | 11.92 (4.81) | 12 | 14.50 (2.47) | 2.69 | .079 | 12 | 11.08 (4.64) | 12 | 10.67 (4.03) | 25 | 10.96 (3.74) | .04 | .966 |
|
| 11 | 5.27 (1.62) | 24 | 9 (3.99) | 12 | 8.42 (3.90) | 4.24 |
| 12 | 7.08 (3.34) | 12 | 7.33 (3.42) | 25 | 7.12 (3.92) | .02 | .983 |
|
| 11 | 9 (3.35) | 24 | 10.63 (3.76) | 12 | 13.08 (4.32) | 3.38 |
| 12 | 10.08 (3.87) | 12 | 9.58 (2.81) | 25 | 10.48 (4.17) | .23 | .798 |
|
| 11 | 17.82 (4.07) | 24 | 15.00 (3.75) | 12 | 19.17 (5.69) | 4.06 |
| 12 | 15.92 (4.36) | 12 | 17.17 (4.80) | 25 | 18.64 (5.04) | 1.36 | .267 |
|
| 11 | 19.36 (3.93) | 24 | 16.88 (4.55) | 12 | 20 (5.56) | 2.17 | .126 | 12 | 17 (4.22) | 12 | 15.75 (4.73) | 25 | 18.76 (5.41) | 1.59 | .215 |
|
| 11 | 15.91 (4.11) | 24 | 14.71 (4.51) | 12 | 15.92 (4.27) | .45 | .642 | 12 | 15.83 (3.30) | 12 | 15.25 (5.14) | 25 | 17.40 (4.96) | 1.02 | .369 |
|
| 8 | 18 (3.61) | 20 | 15.75 (4.78) | 7 | 18.14 (3.44) | .94 | .404 | 11 | 16.73 (3.50) | 7 | 19 (5.95) | 15 | 18.67 (4.27) | .79 | .461 |
*Significant differences among Diagnostic Categories;
**Significant differences among different states of treatment;
***Significant differences in both Diagnostic Categories and State of treatment
ANOVA among the groups in relation to Diagnostic Categories and to the state of treatment (PPI-R, BIS-11 and TAS20 Scales)
| Scales | Diagnostic Categories |
|
|
|
|
| ||||
|---|---|---|---|---|---|---|---|---|---|---|
| Mood Disorder (N=12) | Personality Disorder (N=25) | Psychotic Disorder (N=12) | Conclusion (N=12) | Drop-out (N=12) | In-Treatment (N=25) | |||||
| M (SD) | M (SD) | M (SD) | M (SD) | M (SD) | M (SD) | |||||
|
| 31.64 (3.93) | 31.33 (5.98) | 32.08 (4.60) | .08 | .921 | 31 (5.85) | 32 (4.86) | 29.92 (5.67) | .60 | .554 |
|
| 15.73 (4.15) | 18.38 (4.64) | 19 (4.973) | 1.68 | .198 | 17.58 (5.63) | 17.25 (4.41) | 16.40 (4.24) | .31 | .736 |
|
| 40.45 (7.47) | 42.33 (8.56) | 42 (5.66) | .23 | .795 | 42.75 (8.07) | 45 (5.54) | 41.84 (7.62) | .76 | .473 |
|
| 36.36 (7.92) | 37.54 (7.44) | 39.83 (8.72) | .59 | .557 | 35.92 (7.95) | 37.75 (5.67) | 38.56 (8.01) | .50 | .608 |
|
| 33.45 (7.69) | 37.96 (8.55) | 39.17 (7.91) | 1.59 | .215 | 38.08 (7.63) | 35.83 (6.38) | 37.88 (8.60) | .33 | .722 |
|
| 36.27 (5.37) | 40.71 (9.12) | 43.58 (9.29) | 2.18 | .125 | 41.75 (11.86) | 41.50 (7.09) | 39.04 (6.55) | .60 | .551 |
|
| 43.8 (6.59) | 43.88 (8.37) | 46.33 (5.43) | .51 | .605 | 43.50 (7.60) | 45.75 (6.48) | 47.80 (6.94) | 1.57 | .219 |
|
| 38.45 (8.42) | 38.46 (6.54) | 38.42 (5.73) | .00 | 1 | 37 (6.66) | 41.33 (5.47) | 38.36 (7.24) | 1.34 | .273 |
|
| 32.09 (5.01) | 31.62 (7.87) | 33.33 (3.34) | .29 | .752 | 31.17 (7.66) | 33.17 (5.13) | 31.52 (6.23) | .36 | .700 |
|
| 33.91 (3.51) | 36.88 (5.62) | 32.08 (10.17) | 2.21 | .122 | 36.00 (7.72) | 38.75 (15.41) | 31.88 (6.89) | 2.17 | .126 |
|
| 146.55 (23.24) | 158.54 (21.56) | 164.58 (15.97) | 2.27 | .116 | 158.50 (23.74) | 160.08 (11.51) | 157.32 (21.65) | .076 | .927 |
|
| 114.36 (12.82) | 113.96 (17.18) | 118.08 (10.02) | .33 | .719 | 111.67 (14.95) | 120.25 (9.55) | 117.68 (14.34) | 1.31 | .280 |
|
| 294.82 (31.01) | 309.38 (25.02) | 314.75 (12.19) | 2.13 | .131 | 306.17 (22.12) | 319.08 (21.69) | 306.88 (26.90) | 1.16 | .323 |
|
| 9.56 (2.98) | 10.96 (2.85) | 11.08 (2.47) | 1.15 | .325 | 11.75 (2.70) | 11.33 (2.31) | 10.08 (2.87) | 1.86 | .168 |
|
| 13.18 (2.79) | 15.42 (2.80) | 13.42 (3.29) | 3.08 | . | 14.25 (3.55) | 15.75 (3.02) | 14.56 (3.28) | .74 | .485 |
|
| 12 (2.90) | 16.21 (2.40) | 12.92 (2.50) | 12.99 |
| 16.08 (2.43) | 15.92 (3.15) | 13.68 (2.81) | 4.18 |
|
|
| 13.09 (2.55) | 14.21 (2.78) | 13.42 (1.44) | .92 | .405 | 14.42 (1.83) | 14.08 (1.78) | 12.88 (2.68) | 2.23 | .120 |
|
| 9.45 (1.13) | 8.33 (1.90) | 9 (2.73) | 1.28 | .288 | 8.67 (2.02) | 9.42 (1.08) | 8.88 (2.49) | .41 | .665 |
|
| 5 (1.67) | 6.13 (1.68) | 5.67 (1.07) | 2.02 | .145 | 6.17 (2.25) | 6.08 (1.68) | 6.16 (1.72) | .01 | .992 |
|
| 14.55 (3.67) | 17.08 (3.28) | 16.75 (2.45) | 2.48 | .096 | 17.92 (4.19) | 17.42 (2.02) | 16.24 (3.78) | 1.05 | .359 |
|
| 22.64 (3.04) | 23.75 (4.05) | 22.42 (3.65) | .64 | .531 | 22.92 (4.76) | 25.17 (3.76) | 23.44 (4.10) | .99 | ,379 |
|
| 25.09 (4.64) | 30.42 (4.26) | 26.33 (2.77) | 8.15 |
| 30.50 (3.34) | 30 (4.02) | 26.56 (4.96) | 4.34 |
|
|
| 62.27 (7.93) | 71.25 (8.02) | 65.50 (4.74) | 6.40 |
| 71.33 (9.47) | 72.58 (7.29) | 66.24 (9.93) | 2.39 | .103 |
|
| 14.73 (6.36) | 16.96 (7.85) | 19.50 (7.72) | 1.17 | .321 | 16.75 (8.87) | 17.92 (6.20) | 16.84 (7.32) | .10 | .905 |
|
| 12 (4.31) | 14.83 (5.18) | 13.25 (3.60) | 1.51 | .232 | 14.92 (6.39) | 15.50 (2.50) | 13.28 (3.96) | 1.22 | .304 |
|
| 16.27 (5.20) | 21.17 (3.66) | 19.75 (5.50) | 4.37 |
| 21.75 (4.07) | 19.92 (4.98) | 18.08 (5.67) | 2.12 | .132 |
|
| 43 (13.00) | 52.96 (14.19) | 52.50 (10.49) | 2.37 | .105 | 53.42 (16.52) | 53.33 (9.67) | 48.20 (11.45) | 1.05 | .358 |
*Significant differences among Diagnostic Categories; **Significant differences among different states of treatment; ***Significant differences in both Diagnostic Categories and State of treatment
Classification Results by Discriminant Analysis 1,2
| Treatment | Prediction of Group Membership | ||||
|---|---|---|---|---|---|
| Drop-Out | In-Treatment | Total | |||
| Original | Units | Drop-Out | 9 | 3 | 12 |
| In-Treatment | 6 | 19 | 25 | ||
| Cases number | 27 | 38 | 65 | ||
| % | Drop-Out | 75 | 25 | 100 | |
| In-Treatment | 24 | 76 | 100 | ||
| % Cases | 41.5 | 58.5 | 100 | ||
| Cross-Validated | Units | Drop-Out | 6 | 6 | 12 |
| In-Treatment | 9 | 16 | 25 | ||
| % | Drop-Out | 50 | 50 | 100 | |
| In-Treatment | 36 | 64 | 100 | ||
| 1. 75.7% of the original groups were correctly classified. | |||||
| 2. 59.5% of the cross-validated groups were correctly classified. | |||||